Skip to main content
. 2022 Mar 25;67:102824. doi: 10.1016/j.ctim.2022.102824

Table 4.

Adverse events amongst the study participants.

Variables Hospital Stay
Post Discharge at Day-7 follow-up
Post Discharge at Day-28 follow-up
Post Discharge at Day-42 follow-up
Intervention Control Intervention Control Intervention Control Intervention Control
Mild to moderate category
Nausea 2 4 0 2 0 0 0 0
Flatulence 1 2 1 2 1 1 0 1
Loss of appetite 0 2 0 1 0 1 0 1
Disturbed sleep 0 2 0 2 0 2 0 1
Loose Motion 1 2 0 1 0 1 0 0
Headache 1 1 0 2 0 1 0 1
Epigastric Pain 0 1 0 1 0 0 0 0
Severe category
Nausea 2 4 0 3 0 0 0 0
Disturbed sleep 1 4 0 3 0 2 0 2
Loose Motion 1 2 0 1 0 1 0 0
Burning micturition 0 1 0 0 0 0 0 0
Headache 2 3 0 2 0 1 0 1
Epigastric Pain 0 1 0 0 0 0 0 0
Vomiting 0 2 0 0 0 0 0 0